Chemours Company
(CC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 1,408,000 | 1,376,000 | 1,464,000 | 1,628,000 | 1,816,000 |
| Cost of Goods | 1,085,000 | 1,080,000 | 1,064,000 | 1,151,000 | 1,259,000 |
| Gross Profit | 323,000 | 296,000 | 400,000 | 477,000 | 557,000 |
| Operating Expenses | 162,000 | 186,000 | 229,000 | 195,000 | 191,000 |
| Operating Income | 161,000 | 110,000 | 171,000 | 282,000 | 366,000 |
| Interest Expense | 52,000 | 51,000 | 48,000 | 47,000 | 48,000 |
| Other Income | 24,000 | 48,000 | 59,000 | 34,000 | 5,000 |
| Pre-tax Income | 133,000 | 107,000 | 182,000 | 269,000 | 323,000 |
| Income Tax | 37,000 | 13,000 | 40,000 | -6,000 | 41,000 |
| Net Income Continuous | 96,000 | 94,000 | 142,000 | 275,000 | 282,000 |
| Minority Interests | N/A | N/A | N/A | N/A | 1,000 |
| Net Income | $96,000 | $94,000 | $142,000 | $275,000 | $281,000 |
| EPS Basic Total Ops | 0.58 | 0.56 | 0.85 | 1.56 | 1.58 |
| EPS Basic Continuous Ops | 0.58 | 0.56 | 0.85 | 1.56 | 1.59 |
| EPS Diluted Total Ops | 0.57 | 0.55 | 0.83 | 1.51 | 1.53 |
| EPS Diluted Continuous Ops | 0.58 | 0.55 | 0.83 | 1.51 | 1.53 |
| EBITDA(a) | $241,000 | $189,000 | $244,000 | $355,000 | $442,000 |